Monash University researchers have revealed how the gut—and what we eat—regulates high blood pressure, opening the door to ...

Authorities in the Argentine province of Salta called for tenders to build a “perimeter fence” 200 meters long and 2.5 meters ...

Remedy Pharmaceuticals, the developer of CIRARA (intravenous glyburide) for the treatment of Large Hemispheric Infarction ...

Financial writer recommends Voyager Therapeutics, Inc. for high-risk investors due to promising preclinical Alzheimer's ...

Announcing a new article publication for Zoonoses journal. Methicillin resistant Staphylococcus aureus (MRSA) and Vancomycin ...

Consisting of five separate booklets, the World Drug Report 2022 provides an in-depth analysis of global drug markets and examines the nexus between drugs and the environment within the bigger picture ...

The Damon Runyon Cancer Research Foundation has announced eight recipients of the 2025 Damon Runyon-Rachleff Innovation Award, established to support high-risk, high-reward ideas with the potential to ...

The gut and two cell regulators may pave the way to better high blood pressure drugs.Monash University researchers have revealed how the gut – and ...

The gut and two cell regulators may pave the way to better high blood pressure drugs.Monash University researchers have revealed how the gut - and ...

Drug delivery describes the method and approach to delivering drugs or pharmaceuticals and other xenobiotics to their site of action within an organism, with the goal of achieving a therapeutic ...

Toray Industries Inc has developed a high-efficiency separation membrane module for biopharmaceutical manufacturing processes ...

Rhinitis and pharmacological agents used for treatment are considered factors that could alter the rate and extent of absorption of drugs administered by the nasal route. The purpose of this study ...